Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 4Myasthenia Gravis 1Lymphoma, T-Cell 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Prolymphocytic 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Erythroblastic, Acute 1Leukemia 1

Interventions

Cytarabine 19Daunorubicin 14Etoposide 13Mitoxantrone 8Filgrastim 8Peripheral Blood Stem Cell Transplantation 6Idarubicin 6Gemtuzumab 5Cyclophosphamide 5Radiotherapy 4Observation 4valspodar 3aldesleukin 3Tretinoin 3Busulfan 3sargramostim 2Watchful Waiting 2Thioguanine 2Granulocyte Colony-Stimulating Factor 2Asparaginase 2Amsacrine 2zosuquidar trihydrochloride 1tipifarnib 1midostaurin 1lintuzumab 1laromustine 1fludarabine phosphate 1flt3 ligand protein 1etoposide phosphate 1dexamethasone acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Leukemia, Erythroblastic, Acute × Cladribine × Clear all
NCT00136084 2012-12-05

Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia

St. Jude Children's Research Hospital

Phase 3 Completed
238 enrolled 13 charts
Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡